Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1994 Aug;72(2 Suppl):S31–S35. doi: 10.1136/hrt.72.2_suppl.s31

Electrophysiological disturbances in heart failure

R W F Campbell 1
PMCID: PMC1025571  PMID: 7946755

Full text

PDF
S31

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bourke J. P., Cowan J. C., Tansuphaswadikul S., Campbell R. W. Antiarrhythmic drug effects on left ventricular performance. Eur Heart J. 1987 Mar;8 (Suppl A):105–111. doi: 10.1093/eurheartj/8.suppl_a.105. [DOI] [PubMed] [Google Scholar]
  2. Bristow M. R., Ginsburg R., Minobe W., Cubicciotti R. S., Sageman W. S., Lurie K., Billingham M. E., Harrison D. C., Stinson E. B. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982 Jul 22;307(4):205–211. doi: 10.1056/NEJM198207223070401. [DOI] [PubMed] [Google Scholar]
  3. Brodsky M. A., Allen B. J., Abate D., Henry W. L. Propafenone therapy for ventricular tachycardia in the setting of congestive heart failure. Am Heart J. 1985 Oct;110(4):794–799. doi: 10.1016/0002-8703(85)90459-4. [DOI] [PubMed] [Google Scholar]
  4. Burkart F., Pfisterer M., Kiowski W., Follath F., Burckhardt D. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS) J Am Coll Cardiol. 1990 Dec;16(7):1711–1718. doi: 10.1016/0735-1097(90)90324-i. [DOI] [PubMed] [Google Scholar]
  5. Ceremuzynski L., Kleczar E., Krzeminska-Pakula M., Kuch J., Nartowicz E., Smielak-Korombel J., Dyduszynski A., Maciejewicz J., Zaleska T., Lazarczyk-Kedzia E. Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study. J Am Coll Cardiol. 1992 Nov 1;20(5):1056–1062. doi: 10.1016/0735-1097(92)90357-s. [DOI] [PubMed] [Google Scholar]
  6. Chakko C. S., Gheorghiade M. Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy. Am Heart J. 1985 Mar;109(3 Pt 1):497–504. doi: 10.1016/0002-8703(85)90554-x. [DOI] [PubMed] [Google Scholar]
  7. Chakko S., de Marchena E., Kessler K. M., Myerburg R. J. Ventricular arrhythmias in congestive heart failure. Clin Cardiol. 1989 Sep;12(9):525–530. doi: 10.1002/clc.4960120910. [DOI] [PubMed] [Google Scholar]
  8. Chizner M. A., Pearle D. L., deLeon A. C., Jr The natural history of aortic stenosis in adults. Am Heart J. 1980 Apr;99(4):419–424. doi: 10.1016/0002-8703(80)90375-0. [DOI] [PubMed] [Google Scholar]
  9. Cleland J. G., Dargie H. J., Ford I. Mortality in heart failure: clinical variables of prognostic value. Br Heart J. 1987 Dec;58(6):572–582. doi: 10.1136/hrt.58.6.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cleland J. G., Dargie H. J., Hodsman G. P., Ball S. G., Robertson J. I., Morton J. J., East B. W., Robertson I., Murray G. D., Gillen G. Captopril in heart failure. A double blind controlled trial. Br Heart J. 1984 Nov;52(5):530–535. doi: 10.1136/hrt.52.5.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
  12. Cohn J. N., Levine T. B., Olivari M. T., Garberg V., Lura D., Francis G. S., Simon A. B., Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984 Sep 27;311(13):819–823. doi: 10.1056/NEJM198409273111303. [DOI] [PubMed] [Google Scholar]
  13. Cox J. L., Schuessler R. B., Boineau J. P. The surgical treatment of atrial fibrillation. I. Summary of the current concepts of the mechanisms of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg. 1991 Mar;101(3):402–405. [PubMed] [Google Scholar]
  14. Davies M. J. The current status of myocardial disarray in hypertrophic cardiomyopathy. Br Heart J. 1984 Apr;51(4):361–363. doi: 10.1136/hrt.51.4.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Day C. P., James O. F., Butler T. J., Campbell R. W. QT prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet. 1993 Jun 5;341(8858):1423–1428. doi: 10.1016/0140-6736(93)90879-l. [DOI] [PubMed] [Google Scholar]
  16. De Mazière A. M., Scheuermann D. W. Structural changes in cardiac gap junctions after hypoxia and reoxygenation: a quantitative freeze-fracture analysis. Cell Tissue Res. 1990 Jul;261(1):183–194. doi: 10.1007/BF00329451. [DOI] [PubMed] [Google Scholar]
  17. Dean J. W., Lab M. J. Arrhythmia in heart failure: role of mechanically induced changes in electrophysiology. Lancet. 1989 Jun 10;1(8650):1309–1312. doi: 10.1016/s0140-6736(89)92697-4. [DOI] [PubMed] [Google Scholar]
  18. Eichhorn E. J., Tandon P. K., DiBianco R., Timmis G. C., Fenster P. E., Shannon J., Packer M. Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE Study. J Am Coll Cardiol. 1993 Mar 1;21(3):634–640. doi: 10.1016/0735-1097(93)90095-i. [DOI] [PubMed] [Google Scholar]
  19. Francis G. S. Neuroendocrine manifestations of congestive heart failure. Am J Cardiol. 1988 Jul 11;62(2):9A–13A. doi: 10.1016/s0002-9149(88)80078-x. [DOI] [PubMed] [Google Scholar]
  20. Frohlich E. D. Left ventricular hypertrophy: an independent factor of risk. Cardiovasc Clin. 1990;20(3):85–94. [PubMed] [Google Scholar]
  21. Furberg C. D., Hawkins C. M., Lichstein E. Effect of propranolol in postinfarction patients with mechanical or electrical complications. Circulation. 1984 Apr;69(4):761–765. doi: 10.1161/01.cir.69.4.761. [DOI] [PubMed] [Google Scholar]
  22. Gnecchi M., De Marzio P., Morelli S., Aguglia F. Soppressione di aritmie ventricolari complesse con isosorbide dinitrato in un caso di scompenso cardiaco congestizio. Cardiologia. 1985 May;30(5):401–404. [PubMed] [Google Scholar]
  23. Katz A. M. The heart in congestive failure. Cardioscience. 1990 Mar;1(1):3–6. [PubMed] [Google Scholar]
  24. Luu M., Stevenson W. G., Stevenson L. W., Baron K., Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation. 1989 Dec;80(6):1675–1680. doi: 10.1161/01.cir.80.6.1675. [DOI] [PubMed] [Google Scholar]
  25. Maskin C. S., Siskind S. J., LeJemtel T. H. High prevalence of nonsustained ventricular tachycardia in severe congestive heart failure. Am Heart J. 1984 May;107(5 Pt 1):896–901. doi: 10.1016/0002-8703(84)90824-x. [DOI] [PubMed] [Google Scholar]
  26. McKenna W. J., Harris L., Perez G., Krikler D. M., Oakley C., Goodwin J. F. Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment. Br Heart J. 1981 Aug;46(2):173–178. doi: 10.1136/hrt.46.2.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Moe G. K. Evidence for reentry as a mechanism of cardiac arrhythmias. Rev Physiol Biochem Pharmacol. 1975;72:55–81. doi: 10.1007/BFb0031546. [DOI] [PubMed] [Google Scholar]
  28. Nicklas J. M., McKenna W. J., Stewart R. A., Mickelson J. K., Das S. K., Schork M. A., Krikler S. J., Quain L. A., Morady F., Pitt B. Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Am Heart J. 1991 Oct;122(4 Pt 1):1016–1021. doi: 10.1016/0002-8703(91)90466-u. [DOI] [PubMed] [Google Scholar]
  29. Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
  30. Pfisterer M., Kiowski W., Burckhardt D., Follath F., Burkart F. Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function. Am J Cardiol. 1992 Jun 1;69(17):1399–1402. doi: 10.1016/0002-9149(92)90889-7. [DOI] [PubMed] [Google Scholar]
  31. ROSENBAUM M. B. CHAGASIC MYOCARDIOPATHY. Prog Cardiovasc Dis. 1964 Nov;7:199–225. doi: 10.1016/s0033-0620(64)80020-7. [DOI] [PubMed] [Google Scholar]
  32. Saumarez R. C., Camm A. J., Panagos A., Gill J. S., Stewart J. T., de Belder M. A., Simpson I. A., McKenna W. J. Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms. Circulation. 1992 Aug;86(2):467–474. doi: 10.1161/01.cir.86.2.467. [DOI] [PubMed] [Google Scholar]
  33. Waagstein F., Hjalmarson A., Varnauskas E., Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 1975 Oct;37(10):1022–1036. doi: 10.1136/hrt.37.10.1022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Webster M. W., Fitzpatrick M. A., Nicholls M. G., Ikram H., Wells J. E. Effect of enalapril on ventricular arrhythmias in congestive heart failure. Am J Cardiol. 1985 Sep 15;56(8):566–569. doi: 10.1016/0002-9149(85)91186-5. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES